0001209191-23-037611.txt : 20230615 0001209191-23-037611.hdr.sgml : 20230615 20230615205803 ACCESSION NUMBER: 0001209191-23-037611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bensen Daniel CENTRAL INDEX KEY: 0001880946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 231019162 MAIL ADDRESS: STREET 1: C/O TYRA BIOSCIENCES, INC STREET 2: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-13 0 0001863127 Tyra Biosciences, Inc. TYRA 0001880946 Bensen Daniel C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 0 1 0 0 Chief Operating Officer 1 Common Stock 2023-06-13 4 M 0 5628 0.61 A 533609 D Common Stock 2023-06-13 4 S 0 5628 16.0144 D 527981 D Common Stock 2023-06-14 4 M 0 120 0.61 A 528101 D Common Stock 2023-06-14 4 S 0 120 16.45 D 527981 D Common Stock 2023-06-15 4 M 0 12592 0.61 A 540573 D Common Stock 2023-06-15 4 S 0 12592 16.1453 D 527981 D Stock Option (Right to Buy) 0.61 2023-06-13 4 M 0 5628 0.00 D 2030-01-26 Common Stock 5628 241774 D Stock Option (Right to Buy) 0.61 2023-06-14 4 M 0 120 0.00 D 2030-01-26 Common Stock 120 241654 D Stock Option (Right to Buy) 0.61 2023-06-15 4 M 0 12592 0.00 D 2030-01-26 Common Stock 12592 229062 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.38. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.64. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter. /s/ Ali D. Fawaz, Attorney-in-Fact 2023-06-15